Drug Makers, Providers and Users

A conference recently held in Mumbai highlighted the emerging drug scenario, focusing on the discovery-to-delivery process, IPRs, and the benefits of building alliances in the pharmaceuticals industry. However, the issue of clinical trials, which is of great importance in India given its significance as a clinical trials destination, was not discussed extensively at the meet.